Skip to main content
. 2020 Nov 21;193:104343. doi: 10.1016/j.jpubeco.2020.104343

Table A12.

Robutness to Excluding Potentially “Bad Controls”

(1) (2) (3) (4) (5) (6)
Outcome → Confidence in scientists Scientists working for private companies benefit the public Scientists working for private companies are honest Scientists working for universities benefit the public Scientists working for universities are honest Scientists to find out accurate information
Exposure to Epidemic (18–25) −3.544*** −1.296*** −1.767*** −0.703 −3.365*** −1.626***
(1.344) (0.337) (0.601) (0.465) (0.455) (0.616)
Observations 83,014 81,554 76,856 81,307 76,123 84,104



(1) (2) (3) (4) (5) (6)
Outcome → Have trust in science Science and technology will help improve life Studying diseases is a part of science Have trust in doctors and nurses Have trust in hospitals and health clinics Have trust in traditional healers

Exposure to Epidemic (18–25) 0.114 0.561 0.247 1.557 1.314 −0.615
(0.402) (0.471) (0.446) (1.222) (1.389) (0.545)
Observations 85,368 86,585 88,326 92,026 90,030 87,942
Country fixed effects Yes Yes Yes Yes Yes Yes
Cohort fixed effects Yes Yes Yes Yes Yes Yes
Male dummy Yes Yes Yes Yes Yes Yes
Country-specific age trends Yes Yes Yes Yes Yes Yes

Notes: Results use the Gallup sampling weights and robust standard errors are clustered at the country level. Source: Wellcome Global Monitor, 2018 and EM-DAT International Disaster Database, 1970–2017. * significant at 10%; ** significant at 5%; *** significant at 1%.